Evidence map›Paper›PMID 26159216›Full record

ArticleMolecules and cells2015

Induction of Angiogenesis by Matrigel Coating of VEGF-Loaded PEG/PCL-Based Hydrogel Scaffolds for hBMSC Transplantation.

Yeon Joo Jung, Kyung-Chul Kim, Jun-Young Heo, Kaipeng Jing, Kyung Eun Lee, Jun Seok Hwang, Kyu Lim, Deog-Yeon Jo, Jae Pyoung Ahn, Jin-Man Kim and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Molecules and cells, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yeon Joo JungDepartment of Pharmacology and Medical Research Center, Ewha Womans University School of Medicine, Seoul 158-710, Korea.
Kyung-Chul KimDepartment of Biochemistry, School of Medicine, Chungnam National University, Daejeon 301-747, Korea.
Jun-Young HeoDepartment of Biochemistry, School of Medicine, Chungnam National University, Daejeon 301-747, Korea.
Kaipeng JingDepartment of Biochemistry, School of Medicine, Chungnam National University, Daejeon 301-747, Korea.
Kyung Eun LeeDepartment of Pharmacology and Medical Research Center, Ewha Womans University School of Medicine, Seoul 158-710, Korea.
Jun Seok HwangDepartment of Pharmacology and Medical Research Center, Ewha Womans University School of Medicine, Seoul 158-710, Korea.
Kyu LimDepartment of Biochemistry, School of Medicine, Chungnam National University, Daejeon 301-747, Korea.
Deog-Yeon JoDivision of Hematology/Oncology Department of Internal Medicine, Chungnam National University, Daejeon 301-747, Korea.
Jae Pyoung AhnAdvanced Analysis Center, Korea Institute of Science and Technology, Seoul 136-791, Korea.
Jin-Man KimDepartment of Pathology, School of Medicine, Chungnam National University, Daejeon 301-747, Korea.
Kang Moo HuhDepartment of Polymer Science and Engineering, Chungnam National University, Daejeon 305-764, Korea.
Jong-Il ParkDepartment of Biochemistry, School of Medicine, Chungnam National University, Daejeon 301-747, Korea.
Chungnam National University · KRKorea Institute of Science and Technology · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

hBMSCs are multipotent cells that are useful for tissue regeneration to treat degenerative diseases and others for their differentiation ability into chondrocytes, osteoblasts, adipocytes, hepatocytes and neuronal cells. In this study, biodegradable elastic hydrogels consisting of hydrophilic poly(ethylene glycol) (PEG) and hydrophobic poly(ε-caprolactone) (PCL) scaffolds were evaluated for tissue engineering because of its biocompatibility and the ability to control the release of bioactive peptides. The primary cultured cells from human bone marrow are confirmed as hBMSC by immunohistochemical analysis. Mesenchymal stem cell markers (collagen type I, fibronectin, CD54, integrin1β, and Hu protein) were shown to be positive, while hematopoietic stem cell markers (CD14 and CD45) were shown to be negative. Three different hydrogel scaffolds with different block compositions (PEG:PCL=6:14 and 14:6 by weight) were fabricated using the salt leaching method. The hBMSCs were expanded, seeded on the scaffolds, and cultured up to 8 days under static conditions in Iscove's Modified Dulbecco's Media (IMDM). The growth of MSCs cultured on the hydrogel with PEG/PCL= 6/14 was faster than that of the others. In addition, the morphology of MSCs seemed to be normal and no cytotoxicity was found. The coating of the vascular endothelial growth factor (VEGF) containing scaffold with Matrigel slowed down the release of VEGF in vitro and promoted the angiogenesis when transplanted into BALB/c nude mice. These results suggest that hBMSCs can be supported by a biode gradable hydrogel scaffold for effective cell growth, and enhance the angiogenesis by Matrigel coating.

Indexed as

Neovascularization, PhysiologicAnimalsBone MarrowCells, CulturedCell TransplantationCollagenDrug CombinationsHumansHydrogelsLamininMesenchymal Stem CellsMice, Inbred BALB CPolyestersPolyethylene GlycolsProteoglycansVascular Endothelial Growth Factor ACollagenDrug CombinationsHydrogelsLamininmatrigelpolycaprolactonePolyestersPolyethylene GlycolsProteoglycansVascular Endothelial Growth Factor Aangiogenesiscontrolled releasehBMSChydrogelVEGF

Identifiers

PMID26159216
PMCPMC4507034
OpenAlexW836969484

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.